Phase I study of MP-101 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 03 Oct 2017
At a glance
- Drugs MP 101 (Primary)
- Indications Diabetes mellitus; Neurodegenerative disorders; Neuromuscular disorders; Non-alcoholic steatohepatitis; Obesity
- Focus Adverse reactions; Pharmacokinetics
- 03 Oct 2017 According to a Mitochon Pharmaceuticals media release, this trial is expected to initiate in 2018.
- 26 May 2016 New trial record
- 17 May 2016 According to Mitochon Pharmaceuticals media release, this trial will initiate in 2016.